These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14604653)

  • 1. Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: identification of beta 3-antagonists.
    Saccomanni G; Badawneh M; Adinolfi B; Calderone V; Cavallini T; Ferrarini PL; Greco R; Manera C; Testai L
    Bioorg Med Chem; 2003 Nov; 11(23):4921-31. PubMed ID: 14604653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2, 3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2, 3-b]pyridine:potential antihypertensive agents - part IX.
    Ferrarini PL; Mori C; Badawneh M; Calderone V; Greco R; Manera C; Martinelli A; Nieri P; Saccomanni G
    Eur J Med Chem; 2000 Sep; 35(9):815-26. PubMed ID: 11006483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,8-naphthyridine derivatives: synthesis and pharmacological evaluation of beta-receptor blocking activity.
    Tonetti I; Bertini D; Ferrarini PI; Livi O
    Farmaco Sci; 1976 Mar; 31(3):175-82. PubMed ID: 3435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilipolytic effects of 1,8-naphthyridine derivatives β-adrenoceptor antagonists in rat white adipocytes.
    Aljamal JA; Badawneh M
    Chem Biol Drug Des; 2017 Jul; 90(1):119-127. PubMed ID: 28054456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the biochemical effects of new 1, 8-naphthyridine derivatives, beta-receptor antagonists, in ventricular myocytes.
    Al jamal JA; Badawneh M
    Arch Pharm (Weinheim); 2003 Aug; 336(6-7):285-92. PubMed ID: 12953216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridine isosteres of the -adrenergic antagonists, 2-(p-nitrophenyl)-1-isopropylamino-2-ethanol and 3-(p-nitrophenoxy)-1-isopropylamino-2-propanol.
    Gnewuch CT; Friedman HL
    J Med Chem; 1972 Dec; 15(12):1321-4. PubMed ID: 4404591
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives.
    Wang J; Breslin MJ; Coleman PJ; Duggan ME; Hunt CA; Hutchinson JH; Leu CT; Rodan SB; Rodan GA; Duong LT; Hartman GD
    Bioorg Med Chem Lett; 2004 Feb; 14(4):1049-52. PubMed ID: 15013021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-affinity relationships of 12-sulfonyl derivatives of 5,8,8a,9,10,11,12,12a,13,13a-decahydro-6H-isoquino[2,1-g][1 ,6] naphthyridines at alpha-adrenoceptors.
    Clark RD; Repke DB; Berger J; Nelson JT; Kilpatrick AT; Brown CM; MacKinnon AC; Clague RU; Spedding M
    J Med Chem; 1991 Feb; 34(2):705-17. PubMed ID: 1671705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, docking study and β-adrenoceptor activity of some new oxime ether derivatives.
    Ghabbour HA; El-Bendary ER; El-Ashmawy MB; El-Kerdawy MM
    Molecules; 2014 Mar; 19(3):3417-35. PubMed ID: 24658567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological activities of 1,8-naphthyridine derivatives.
    Leonard JT; Gangadhar R; Gnanasam SK; Ramachandran S; Saravanan M; Sridhar SK
    Biol Pharm Bull; 2002 Jun; 25(6):798-802. PubMed ID: 12081151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives.
    Ferrarini PL; Mori C; Manera C; Martinelli A; Mori F; Saccomanni G; Barili PL; Betti L; Giannaccini G; Trincavelli L; Lucacchini A
    J Med Chem; 2000 Jul; 43(15):2814-23. PubMed ID: 10956189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomers of 8-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H- (1,4)benzothiazine: racemic resolution, chiral synthesis and biological activity.
    Schiaffella F; Fringuelli R; Cecchetti V; Fravolini A; Angeli P; Marucci G
    Farmaco; 1990 Dec; 45(12):1299-307. PubMed ID: 1982489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, pharmacological activity and chromatographic separation of some novel potential beta-blockers of the aryloxyaminopropanol type.
    Cizmáriková R; Racanská E; Hrobonova K; Lehotay J; Aghová Z; Halesová D
    Pharmazie; 2003 Apr; 58(4):237-41. PubMed ID: 12749403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: synthesis, SAR and biological evaluation.
    Madsen-Duggan CB; Debenham JS; Walsh TF; Yan L; Huo P; Wang J; Tong X; Lao J; Fong TM; Xiao JC; Huang CR; Shen CP; Stribling DS; Shearman LP; Strack AM; Goulet MT; Hale JJ
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3750-4. PubMed ID: 20483606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, binding affinity and selectivity of new beta 1- and beta 2-adrenoceptor blockers.
    Brizzi V; Francioli M; Brufani M; Filocamo L; Bruni G; Massarelli P
    Farmaco; 1999; 54(11-12):713-20. PubMed ID: 10668169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.